Navigation Links
Closing the Gap Between Patient Expectations and Patient Portals
Date:7/12/2013

MOUNTAIN VIEW, Calif., July 12, 2013 /PRNewswire/ --

WHEN:

12:00 p.m. EDT, Wednesday, July 17, 2013

LOCATION:

Online, with complimentary registration

SPEAKERS:

Healthcare Senior Vice President Greg Caressi

"Patient engagement" is one of the hot terms in the healthcare world today, frequently a discussion that occurs without the involvement of patients. What patient engagement and patient empowerment mean often depends on where you sit in the healthcare value chain. Patient goals and expectations for engagement are often different from those of providers, payers and employers. Over the next few years, some of the biggest changes we will see in healthcare include an increase in patient-provider interaction, as well as a rise in patient responsibility, choice and control of data.

Gain insight into key market uncertainties:

  • How are patient expectations changing regarding interaction with healthcare payers and providers?
  • What are the goals of accountable care organizations (ACOs) in patient engagement, and what solutions are needed to support these goals?
  • How do current IT solutions measure up and where are the gaps?
  • How will the increasing impact of consumerism and patient empowerment create new opportunities to provide healthcare IT solutions directly to individuals/patients?
  • What surprises are in store for patients, payers and providers in patient engagement and empowerment over the next few years?

This webinar is beneficial for all stakeholders in the healthcare ecosystem, including payers and providers, as well as healthcare vendors, suppliers and investors.  This complimentary briefing will feature shifts in the healthcare market that have a wide-ranging impact, reaching markets traditionally outside the realm of patient care.   

Supporting Quote

"Direct engagement with individuals (patients) is one of the key systematic changes being used to meet Meaningful Use requirements and to achieve goals of population health management," said Frost & Sullivan Senior Vice President Greg Caressi.  "The buzz and talk around patient engagement is thick, but the reality is there are significant gaps in the IT tools and expectations of patients and providers in what they want to get out of 'patient engagement.' Discussions with patients, healthcare providers and solution providers have shown where these gaps are and how they can be bridged.  Hint: it is not likely that this will occur through the current solutions."

Registration

To attend the briefing, email britni.myers@frost.com your full name, job title, company name, company telephone number, company email address and website, city, state and country.

Supporting Resources

For more information about Frost & Sullivan's Connected Health practice, please visit: http://connectedhealth.frost.com

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

  • The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
  • The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us:     Start the discussion

Join Us:           Join our community

Subscribe:       Newsletter on "the next big thing"

Register:        Gain access to visionary innovation

Contact:
Britni Myers
Frost & Sullivan
+1.210.477.8481
britni.myers@frost.com


'/>"/>
SOURCE Frost & Sullivan
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Concord Medical Announces its Successful Closing of the Acquisition of 52% Ownership in Changan Hospital and Provides Guidance for Financial Results of the Second Quarter of 2012
2. Omeros Announces Closing of $34.5 Million Public Offering of Common Stock
3. Ampio Pharmaceuticals Announces Closing of Public Offering
4. Rosetta Genomics Announces Exercise and Closing of Underwriters Over-Allotment Option
5. Medisafe 1 Technologies Announces Delay in Closing $7MM Perpetual License Sale Due to Hurricane Sandy
6. AspenBio Pharma Announces Closing of Public Offering of 1,946,000 Shares of Common Stock
7. Trovagene Announces Closing of Private Placement of $3.76 Million from the Sale of Restricted Common Stock and Warrants
8. Winner Medical Announces Closing of Going Private Transaction
9. Pharmaceuticals Announces $1.5 Million Second Closing in Private Placement
10. NewLink Genetics Corporation Announces Exercise of Underwriters Option and Closing of Public Offering of Common Stock
11. Echo Therapeutics Announces Closing of Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... Feb. 23, 2017 ITL Limited, ( ASX: ITD ), ... for the half year ended 31 December 2016 compared with the ... presentation can be viewed here . Highlights ... $1.04m; up 104%) Earnings per share of 2.2 ... of $17.5m (Dec 2015: $15.7m; up 11%) Profit ...
(Date:2/23/2017)... -- Research and Markets has announced the addition of ... report to their offering. ... The latest research Oesophageal Cancer Drugs Price Analysis ... the global Oesophageal Cancer market. The research answers the ... drugs marketed for Oesophageal Cancer and their clinical attributes? How are ...
(Date:2/23/2017)... , February 23, 2017 Obese ... increasing caseload for varicose veins in their body. The ... are prompting the adoption of endovenous laser therapy for ... endovenous laser therapy market, published by Future ... lifestyle choices and consequences of obesity have collectively factored ...
Breaking Medicine Technology:
(Date:2/24/2017)... , ... February 24, 2017 , ... ... into the Senior International Elite division on February 12th. Ms. Esparza qualified ... at the elite qualifier competition held in Las Vegas, Nevada. Frida is one ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... an official 2017 partnership with The Jensie Gran Fondo of Marin. For the ... UVB rays with Thinksport’s broad-spectrum, mineral-based sunscreen. , “We are thrilled to provide ...
(Date:2/23/2017)... ... February 23, 2017 , ... The 89th Academy Awards will be celebrated this ... Education Policy Center Bunkum Award. We invite you to enjoy our 11th annual tongue-in-cheek ... winner is the Center for American Progress (CAP), for its report, Lessons From State ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... clinician-based audience, will be participating in Rare Disease Day events, hosted by the ... addition, Rare Disease Report, a website, weekly e-newsletter and quarterly publication, will be ...
(Date:2/23/2017)... ... February 23, 2017 , ... Los Angeles-based weight loss surgeon Michael Feiz, ... June: From Not to Hot,” which will begin airing on February 24, 2017. The ... millions from the 2012 reality television series, “Here Comes Honey Boo Boo.” The earlier ...
Breaking Medicine News(10 mins):